WO2001030364A1 - Method and apparatus for processing blood and blood components - Google Patents

Method and apparatus for processing blood and blood components Download PDF

Info

Publication number
WO2001030364A1
WO2001030364A1 PCT/SE2000/001077 SE0001077W WO0130364A1 WO 2001030364 A1 WO2001030364 A1 WO 2001030364A1 SE 0001077 W SE0001077 W SE 0001077W WO 0130364 A1 WO0130364 A1 WO 0130364A1
Authority
WO
WIPO (PCT)
Prior art keywords
bag
bags
blood
diluting solution
accordance
Prior art date
Application number
PCT/SE2000/001077
Other languages
French (fr)
Inventor
Niclas HÖGBERG
Emanuel HÄLLGREN
Peter Pihlstedt
Original Assignee
Sanguistech Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanguistech Ab filed Critical Sanguistech Ab
Priority to EP00935797A priority Critical patent/EP1223954B1/en
Priority to AT00935797T priority patent/ATE290389T1/en
Priority to AU51205/00A priority patent/AU5120500A/en
Priority to JP2001532782A priority patent/JP2003535815A/en
Priority to DE60018590T priority patent/DE60018590T2/en
Publication of WO2001030364A1 publication Critical patent/WO2001030364A1/en
Priority to US10/000,464 priority patent/US6740239B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3693Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02Blood transfusion apparatus
    • A61M1/0209Multiple bag systems for separating or storing blood components
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3692Washing or rinsing blood or blood constituents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3693Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
    • A61M1/3696Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging with means for adding or withdrawing liquid substances during the centrifugation, e.g. continuous centrifugation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40Mixing liquids with liquids; Emulsifying
    • B01F23/405Methods of mixing liquids with liquids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F31/00Mixers with shaking, oscillating, or vibrating mechanisms
    • B01F31/20Mixing the contents of independent containers, e.g. test tubes
    • B01F31/23Mixing the contents of independent containers, e.g. test tubes by pivoting the containers about an axis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2101/00Mixing characterised by the nature of the mixed materials or by the application field
    • B01F2101/2202Mixing compositions or mixers in the medical or veterinary field
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F23/00Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
    • B01F23/40Mixing liquids with liquids; Emulsifying
    • B01F23/48Mixing liquids with liquids; Emulsifying characterised by the nature of the liquids
    • B01F23/483Mixing liquids with liquids; Emulsifying characterised by the nature of the liquids using water for diluting a liquid ingredient, obtaining a predetermined concentration or making an aqueous solution of a concentrate

Definitions

  • the claimed invention relates to a method and an apparatus for pre-processing blood concentrate products before they are exposed to continued processing for extracting those remaining subcomponents that are of interest
  • the pre-processing of blood concentrate products, p ⁇ ma ⁇ ly pertaining to the invention entails a resolution of these in a diluting solution and a flushing of the containers or bags in which the blood concentrate products are delivered This makes possible the following processing operation m the form of cent ⁇ fuging and the dividing up of blood concentrate products into blood-platelet plasma and waste products
  • the invention is p ⁇ ma ⁇ ly intended for pre-processing of such blood concentrate products that are designated "Buffy Coat” at blood-donor centres and which are obtained from red blood cells and plasma from whole blood and which at present are utilised for extracting valuable medicinal blood-platelet plasma.
  • the Buffy Coat is a thick viscous liquid that must be resolved m a suitable diluting solution before it can be exposed to renewed cent ⁇ fuging
  • T-Sol An example of such a standardised diluting solution, which is widely used, is generally designated T-Sol
  • the Buffy coat is accessible in the form of concentrate from the previous extraction of red blood cells and plasma from whole blood
  • Each concentrate batch of Buffy Coat is, as a rule, too small to be worth an individual cent ⁇ fuging after resolution in the current diluting solution
  • a decided amount of diluting solution was previously added manually to each one of a certain amount of blood processing bags and shaken manually until an acceptable mixing had taken place, followed by emptying them together into a larger bag which was then cent ⁇ fuged
  • the added ⁇ sk to the person who must shake the blood bags and in the long term can receive injury to the neck and shoulders
  • the addition of the diluting solution to the Buffy Coat bags is then controlled by the clamp valve, which, in turn, is controlled by a control program that can be included in the control program of the control system of the centrifuge, which also selects the time to start the motor and the time it must be operated.
  • the diluting solution is added in several portions with a motor driven action between each addition. Dissolving the Buffy Coat in the diluting solution is thus carried out without any manual shaking operation. Due to the special timed movement, back and forth, of the motor the problem of damaging the different tubes is avoid. It is only the ring bag and the tube between it and the final product's storage bag that are affected by the mixing operation.
  • the content of all bags are added to the bag set included in the ring bag via a separate connecting tube, which also is connected to the previously named multi-way connector and which on its way to the ring bag is placed in a clamp valve by which this connection is controlled.
  • the connection is interrupted between the ring bag and the exit bags and the diluting solution bag, the appropriate connecting tube is removed by welding from the centrifuge rotor support which it passes, after which the empty bags and their connecting tubes can be rejected. Following this the diluting solution/Buffy Coat mix is centrifuged while the bag intended for storing the end product is located in the centre chamber of the centrifuge rotor.
  • the designed device is utilised in a known way to expose the ring bag to an outer pressure thus emptying it to a greater or lesser degree.
  • This device consists of a membrane arranged under the ring bag under which hydraulic fluid can be added and therefore expose the ring bag to an external pressure.
  • emptying the ring bag must be interrupted it is determined by one or more photocells in the outer lid of the centrifuge, which utilise the difference in colour between the light desired blood- platelet 's end product and those dark heavy concentrate products that are gathered along the outer periphery.
  • the connecting tube between the ring bag and final storage bag is welded in a known way and thereby blocking the ends of both tubes. All that remains after that is to point out that the holder for the diluting solution bag and cassette for the Buffy Coat bags can be made removable in order not to interfere with the other functions of the centrifuge.
  • Fig. 1 a bag set intended for blood-platelet production from Buffy Coat
  • Fig. 2 angle projection of the equipped centrifuge in accordance with the invention for autopooling.
  • tube 30 connecting to diluting solution 23 there is a breaker switch 45 which, when required to add the diluting solution to tubes 25-28, which are connected to the bags with Buffy Coat, can be opened by sharply bending the tube Before the breaker switch is opened the connecting tube 30 must be engaged in guide groove 12 in one of the supports 9-11 with which the clamp valve function is intended to control
  • cent ⁇ fuge 34 is shown standing with its outer lid 35 completely open and locked in position
  • the inner hd of the cent ⁇ fuge has not been taken into account m the figure as it made the figure unclear when drawn in position
  • the cent ⁇ fuge rotor and ⁇ ng bag 22 has been drawn, to a certain extent, in a simplified way
  • the control panel of the cent ⁇ fuge is numbered 36 in the figure
  • the figure shows a position with four blood bags of Buffy Coat 37-40 suspended m a cassette 41, which is mounted on the outer lid of the cent ⁇ fuge
  • the respective outlets of blood bags 37-40 have, by ste ⁇ le welding, been connected to tube connectors 25-28 and the fluid content of the bags has been transferred to ⁇ ng bag 22 via these tubes and connecting tube 31
  • bags 37-40 have received cleaning and diluting fluid from the diluting fluid bag 23
  • Flushing out of the blood bags can, if, necessary be carried out as two or several consecutive flushing stages.
  • the centrifuge is closed and centrifuging is carried out.
  • Final storage bag 33 is located in centre chamber 45 of the centrifuge. After centrifuging all blood-platelet plasma is transferred to final storage bag 33 via location 5, under the ring bag, being supplied by hydraulic fluid which exposes the bag to an outer pressure which clamps it together.
  • Emptying the ring bag is interrupted by photocell 52 when it registers that the interface between the desired lighter substance and the darker non-desired concentrate product starts to reach the outlet via tube 32. Following this, tube 32 is sterile welded and sealed in one of the supports 9-11, after which the ring bag with the non-desired concentrates of red blood cells, etc. can be rejected.

Abstract

The claimed invention relates to a method and a device for processing blood concentrate products before they are exposed to a continued process for extracting those remaining medicinally interesting sub-components. The appropriate pre-processing, in relation to the invention, primarily entails a mechanically powered resolution of the viscous flowing concentrate products in a diluting solution for the adaptation of the total products for a renewed centrifuging.

Description

Method and apparatus for processing blood and blood components
The claimed invention relates to a method and an apparatus for pre-processing blood concentrate products before they are exposed to continued processing for extracting those remaining subcomponents that are of interest The pre-processing of blood concentrate products, pπmaπly pertaining to the invention, entails a resolution of these in a diluting solution and a flushing of the containers or bags in which the blood concentrate products are delivered This makes possible the following processing operation m the form of centπfuging and the dividing up of blood concentrate products into blood-platelet plasma and waste products
The invention is pπmaπly intended for pre-processing of such blood concentrate products that are designated "Buffy Coat" at blood-donor centres and which are obtained from red blood cells and plasma from whole blood and which at present are utilised for extracting valuable medicinal blood-platelet plasma. At this stage the Buffy Coat is a thick viscous liquid that must be resolved m a suitable diluting solution before it can be exposed to renewed centπfuging An example of such a standardised diluting solution, which is widely used, is generally designated T-Sol In normal cases the Buffy coat is accessible in the form of concentrate from the previous extraction of red blood cells and plasma from whole blood Each concentrate batch of Buffy Coat is, as a rule, too small to be worth an individual centπfuging after resolution in the current diluting solution As every Buffy Coat concentrate is initially accessible in its own blood processing bag, a decided amount of diluting solution was previously added manually to each one of a certain amount of blood processing bags and shaken manually until an acceptable mixing had taken place, followed by emptying them together into a larger bag which was then centπfuged Apart from the manual handling and the time required for this there is also the added πsk to the person who must shake the blood bags and in the long term can receive injury to the neck and shoulders
To be able to also automate this stage in blood processing it is suggested, in accordance with the claimed invention, the use of a specially intended set of bags preferably containing a πng-shaped bag for the following centπfuging operation as well as the use of a characteπstic automatic mixing device, special to the invention, m which the Buffy coat is added and resolved in a diluting solution In the design of this part of the invention, preferred, by us the mixing function or the mixing device has been built into or made connectable to the outer lid of the centπfuge that is utilised in the processing stage that follows after Nevertheless, the device can also be made to stand completely by itself without changing the oπginal concept In the device, in accordance with the invention, a smaller electπcally dπven motor is thus included which, when the device is combined with the centπfuge, is secured to the lid of the centπfuge This motor has the distinct feature of never doing a complete revolution m any direction but is quickly stopped before a revolution is completed then followed by an incomplete revolution in the opposite direction A movement of approximately one of quarter revolution (such as +92°), at the most lasting several minutes, has shown that it gives the desired mixing function, which, as shown as follows, has, as its task the replacement of the pπor manual resolution of the Buffy Coat and the flushing out of the Buffy Coat bags with the required amount of diluting solution, which, today was generally preceded by Pooling, in other words, the merging of several flushed out quantities of concentrate products to form a mass that is suitable for centπfuging The device's special movement pattern can be attained with a gear box, a crank function or via the control of its motor In theory, a hydraulic motor could also be used for this purpose although a longer shaking rate and a longer mixing time should be taken into account Connected to the aforementioned motor there is a cassette or holder in which the number of concentrate bags with Buffy Coat intended to be included in a process can be connected Before the concentrate bags are connected to the cassette they have been individually connected by sterile welding to individual connecting tubes then to the bag set intended for processing, which, in turn, leads to a connecting tube with which all bags containing Buffy Coat can be joined to a bag with the required amount of diluting solution, as well as via a second connecting tube to the ring bag intended for finishing centrifuging and finally to a connecting tube between the ring bag and a storage bag for the desired final product. Together these components make up a functionally sealed system which is easy to handle and completely protected against external bacteria, etc.
When extracting blood platelet plasma from the Buffy coat the number of bags with the original material that are intended for centrifuging are connected to individual connecting tubes in the aforementioned bag set. These connecting tubes are then connected, each in turn, to a multi-way connector to which the connecting tube form the diluting solution bag is also connected. A clamp valve is applied to the latter connecting tube while the bags with Buffy Coat are secured to the aforementioned cassette and the bag with the diluting solution is suspended in the intended holder sufficiently high up to allow the desired amount of diluting solution to be transferred to each respective Buffy Coat bag. The addition of the diluting solution to the Buffy Coat bags is then controlled by the clamp valve, which, in turn, is controlled by a control program that can be included in the control program of the control system of the centrifuge, which also selects the time to start the motor and the time it must be operated. Appropriately, the diluting solution is added in several portions with a motor driven action between each addition. Dissolving the Buffy Coat in the diluting solution is thus carried out without any manual shaking operation. Due to the special timed movement, back and forth, of the motor the problem of damaging the different tubes is avoid. It is only the ring bag and the tube between it and the final product's storage bag that are affected by the mixing operation. After the dissolution of the Buffy Coat in the different exit bags is finalised the content of all bags are added to the bag set included in the ring bag via a separate connecting tube, which also is connected to the previously named multi-way connector and which on its way to the ring bag is placed in a clamp valve by which this connection is controlled. After all substance has been transfeπed to the ring bag the connection is interrupted between the ring bag and the exit bags and the diluting solution bag, the appropriate connecting tube is removed by welding from the centrifuge rotor support which it passes, after which the empty bags and their connecting tubes can be rejected. Following this the diluting solution/Buffy Coat mix is centrifuged while the bag intended for storing the end product is located in the centre chamber of the centrifuge rotor. After centrifuging the lighter blood platelet product is transferred to the final storage bag. The designed device is utilised in a known way to expose the ring bag to an outer pressure thus emptying it to a greater or lesser degree. This device consists of a membrane arranged under the ring bag under which hydraulic fluid can be added and therefore expose the ring bag to an external pressure. When emptying the ring bag must be interrupted it is determined by one or more photocells in the outer lid of the centrifuge, which utilise the difference in colour between the light desired blood- platelet 's end product and those dark heavy concentrate products that are gathered along the outer periphery. When emptying the ring bag it is suitable to do it via the already described cell trap, which can, for example, be one of the types, described in WO 97/30715. After the desired amount of blood-platelet plasma has been removed from the ring bag the connecting tube between the ring bag and final storage bag is welded in a known way and thereby blocking the ends of both tubes. All that remains after that is to point out that the holder for the diluting solution bag and cassette for the Buffy Coat bags can be made removable in order not to interfere with the other functions of the centrifuge.
The invention in its various functions has now been defined in the subsequent patent claims and they shall now only be somewhat more described in relation to the attached figures.
Of these
Fig. 1 a bag set intended for blood-platelet production from Buffy Coat
Fig. 2 angle projection of the equipped centrifuge in accordance with the invention for autopooling. The bag shown in Fig 1 for blood-platelet production from Buffy Coat compπses πng bag 22, a bag for diluting solution 23, four connecting tubes 25-28 (the number of connecting tubes can vary but should as a rule be between 4 and 6), each one is intended for welding to one bag of Buffy Coat, a multi-way connector 29 which, on the one hand, is connected via tube 30 to the diluting solution bag 23 and, on the other hand, to another tube 31 to πng bag 22 From the latter there is one more tube 32 that finally goes to final storage bag 33 In tube 30 connecting to diluting solution 23 there is a breaker switch 45, which, when required to add the diluting solution to tubes 25-28, which are connected to the bags with Buffy Coat, can be opened by sharply bending the tube Before the breaker switch is opened the connecting tube 30 must be engaged in guide groove 12 in one of the supports 9-11 with which the clamp valve function is intended to control the added diluting solution
As the bag set shown in Fig 1 is the same as illustrated in Figure 2 we have retained the same notations although the parts are drawn to a smaller scale and consequently also with fewer parts Otherwise, in Fig 2 centπfuge 34 is shown standing with its outer lid 35 completely open and locked in position The inner hd of the centπfuge has not been taken into account m the figure as it made the figure unclear when drawn in position Also the centπfuge rotor and πng bag 22 has been drawn, to a certain extent, in a simplified way The control panel of the centπfuge is numbered 36 in the figure Furthermore, the figure shows a position with four blood bags of Buffy Coat 37-40 suspended m a cassette 41, which is mounted on the outer lid of the centπfuge The respective outlets of blood bags 37-40 have, by steπle welding, been connected to tube connectors 25-28 and the fluid content of the bags has been transferred to πng bag 22 via these tubes and connecting tube 31 After that, bags 37-40 have received cleaning and diluting fluid from the diluting fluid bag 23 suspended in holder 44 Diluting fluid bag 23 is suspended sufficiently high above bags 37-40 to enable the diluting solution, in sufficient amounts, to be added to the bags as soon as breaker switch 45 in tube 30 and clamp valve in support 11, which tube 30 passes, is opened. Communication between bags 37-40 and ring bag 22 is via tube 31 which, in turn, passes clamp valve in support 10 by which communication is controlled. As the addition of diluting solution in sufficient amounts to the bags 37^0 starts with the cassette connected motor (not seen on the figure) that operates cassette 41 forwards and backwards in a pendulum movement, in accordance with curve 42, until all the concentrate substance in the Buffy Coat bags has dissolved, after which the built-in clamp valve on support 10 opens up, which outlet tube 31 from multi-way connector 29 passes through and all substance is added to ring bag 22 after which tube 31, in support 10 is sterile welded and blocked whereby the empty bags 37^.0 and bag 23 with the concentrate from the diluting solution can be rejected together with the tube system. Flushing out of the blood bags can, if, necessary be carried out as two or several consecutive flushing stages. After the prepared flushing of the blood bags cassette 41 and holder 44 are removed from the centrifuge lid the centrifuge is closed and centrifuging is carried out. Final storage bag 33 is located in centre chamber 45 of the centrifuge. After centrifuging all blood-platelet plasma is transferred to final storage bag 33 via location 5, under the ring bag, being supplied by hydraulic fluid which exposes the bag to an outer pressure which clamps it together. Emptying the ring bag is interrupted by photocell 52 when it registers that the interface between the desired lighter substance and the darker non-desired concentrate product starts to reach the outlet via tube 32. Following this, tube 32 is sterile welded and sealed in one of the supports 9-11, after which the ring bag with the non-desired concentrates of red blood cells, etc. can be rejected.

Claims

Case 3809 Patent Claims
1. The way of pre-processing blood concentrate products from a previous centrifuging of whole blood before these concentrate products are exposed to yet another centrifuging for separating the recoverable, still accessible, medicinally valuable components, characterised by the number of bags (37-40) with blood concentrate products that are intended to be included in the current new centrifuging, along with the respective bag and outlet tubes (25-28) connected to multi-way connector (29) to which also bag (23) with diluting solution is joined to supply tube (30) is connected, after which bags (37^40) with blood concentrate products are suspended in cassette (41) which, via the adapted motor, can operate forwards and backwards in an incomplete pendulum swing (42) while the diluting fluid in adapted portions is added to the bags with the blood concentrate products from bag (23) with diluting solution and whereby cassette (41) is kept in motion by the motor until all concentrate products are dissolved in the added diluting solution, after which the content of all bags in the cassette are added to a new bag (22) for the subsequent centrifuging.
2. Method in accordance with Claim 1 characterised in which the amount of diluting solution added to each respective bag is controlled by clamp valve (11) through which the supply tube (30), for the diluting solution, passes and which clamp valve (11) can also be utilised for when processing is finalised to weld the tube.
3. Method in accordance with Claim 1 or 2 characterised in which the pendulum movement of cassette (41) is held within +/- approx. a quarter revolution.
4. Method in accordance with either of Claims 1-3 characterised in which the content in all bags with blood concentrate products (37-40) after the addition of and processing with the diluting solution via a joint multi-way valve (29) to which the tubes are connected then transferred to ring bag (22) in which the consequent centrifuging is carried out.
5. Method in accordance with either of Claims 1—4 that is characterised by the addition of diluting solution and transference of dissolved concentrate products takes place in several steps with mixing as the middle step.
6. Device for carrying out the method in accordance with either of Claims 1-5 that is characterised by cassette (41) in which a number of standard bags (37-40) with blood concentrate products from a previous centrifuging can be suspended and also via multi-way valve (29) can be connected to source (23) for the controlled addition of diluting fluid and whereby cassette (41) can be put in motion by a motor in a forward and backward pendulum movement (42) consisting only of an incomplete revolution about the axis.
7. Device in accordance with Claim 6 that is characterised by also containing an instrument for introducing a holder or bag with diluting solution, which via a control valve is connected to the same multi-way control valve as the bags with blood concentrate products.
8. Device in accordance with Claim 6 or 7 that is characterised thereof by the pendulum movement of the motor being within the interval +/- approximately a quarter revolution.
9. Bag set for processing blood concentrate products in accordance with the method as per either Claim 1—4 and/or device in accordance with either of Claims 6-8 that is characterised thereof by containing ring bag (22), bag (23) with diluting solution, more than two connecting tubes (25-28) that are intended to be individually connected to a bag with blood concentrate products and to multi-way connector (29) whereby the aforementioned connecting tubes and bag (23) with the diluting solution and ring bag (22) all are connected to the multi-way connector where they can be connected with each other while a final storage bag (33) is separately connected to the ring bag.
10. Centrifuge (34) for carrying out the method in accordance with either of
Claims 1-5 is characterised thereby its outer lid (35) having a motor with the special function for activating an incomplete revolution (42) immediately followed by a corresponding incomplete return revolution to and past the point of departure and that this function can be combined with a holder or cassette (41) and when the centrifuge's outer lid (35) is fully open a number of bags (37—40) can be suspended for when the motor is activated they are exposed to a mechanical mixing of the existing substance inside.
PCT/SE2000/001077 1999-10-26 2000-05-26 Method and apparatus for processing blood and blood components WO2001030364A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP00935797A EP1223954B1 (en) 1999-10-26 2000-05-26 Method and apparatus for processing blood and blood components
AT00935797T ATE290389T1 (en) 1999-10-26 2000-05-26 METHOD AND APPARATUS FOR TREATING BLOOD AND BLOOD COMPONENTS
AU51205/00A AU5120500A (en) 1999-10-26 2000-05-26 Method and apparatus for processing blood and blood components
JP2001532782A JP2003535815A (en) 1999-10-26 2000-05-26 Method and apparatus for processing blood and blood components
DE60018590T DE60018590T2 (en) 1999-10-26 2000-05-26 METHOD AND APPARATUS FOR THE TREATMENT OF BLOOD AND BLOOD COMPONENTS
US10/000,464 US6740239B2 (en) 1999-10-26 2001-11-30 Method and apparatus for processing blood and blood components

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9903841A SE517032C2 (en) 1999-10-26 1999-10-26 Method and apparatus for treating blood and blood components
SE9903841-6 1999-10-26

Publications (1)

Publication Number Publication Date
WO2001030364A1 true WO2001030364A1 (en) 2001-05-03

Family

ID=20417474

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE2000/001077 WO2001030364A1 (en) 1999-10-26 2000-05-26 Method and apparatus for processing blood and blood components

Country Status (8)

Country Link
US (1) US6740239B2 (en)
EP (1) EP1223954B1 (en)
JP (1) JP2003535815A (en)
AT (1) ATE290389T1 (en)
AU (1) AU5120500A (en)
DE (1) DE60018590T2 (en)
SE (1) SE517032C2 (en)
WO (1) WO2001030364A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7708889B2 (en) 2002-04-16 2010-05-04 Caridianbct, Inc. Blood component processing system method

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9700495D0 (en) * 1997-02-12 1997-02-12 Omega Medicinteknik Ab Method and round bag system and centrifuge for blood treatment
AU2004202457B2 (en) * 1999-05-31 2006-04-27 Terumo Bct, Inc. Centrifuge for processing blood and blood components in ring type blood processing
SE516321C2 (en) * 1999-05-31 2001-12-17 Gambro Inc Centrifuge for the treatment of blood and blood components
US7347932B2 (en) * 2003-08-25 2008-03-25 Gambro Bct, Inc. Apparatus and method for separating a volume of composite liquid into at least two components
EP1796757A1 (en) * 2004-09-09 2007-06-20 Lifeforce Group PLC Apheresis tubing set
ATE452668T1 (en) * 2004-12-28 2010-01-15 Caridianbct Inc APPARATUS AND METHOD FOR SEPARATING A QUANTITY OF BLOOD INTO FOUR COMPONENTS
WO2007024518A2 (en) * 2005-08-22 2007-03-01 Gambro Inc. Apparatus and method for separating a composite liquid into at least two components
US20070102858A1 (en) * 2005-11-07 2007-05-10 Navigant Biotechnologies, Inc. Clamps and methods for displacing fluid from portions of fluid containers
EP2213376B1 (en) * 2006-06-07 2012-11-28 Terumo BCT, Inc. Method for separating a composite liquid into at least two components
AU2007292504A1 (en) * 2006-09-06 2008-03-13 Caridianbct, Inc. Apparatus and method for separating a composite liquid into at least two components
US8287742B2 (en) * 2006-12-20 2012-10-16 Terumo Bct, Inc. Method for separating a composite liquid into at least two components
US20080234622A1 (en) * 2007-03-20 2008-09-25 Gambro Bct Inc. Methods and Systems for Preparing Blood Products
EP2764879B1 (en) * 2007-05-14 2016-06-29 Terumo BCT, Inc. Apparatus and method for collecting four components from a composite blood product
WO2009134521A1 (en) * 2008-05-02 2009-11-05 Caridianbct, Inc. Centrifuge apparatus and method for selectively reducing forces on a biologic fluid
JP5554778B2 (en) * 2008-07-31 2014-07-23 テルモ ビーシーティー、インコーポレイテッド Method and apparatus for determining the yield of at least one component
EP2576073B1 (en) 2010-06-07 2018-06-13 Terumo BCT, Inc. Multi-unit blood processor with volume prediction
WO2012012343A1 (en) 2010-07-19 2012-01-26 Caridianbct, Inc. A centrifuge for processing blood and blood components
WO2013106605A1 (en) 2012-01-11 2013-07-18 Terumo Bct Biotechnologies, Llc Slidable clamp for port isolation
US9968738B2 (en) 2014-03-24 2018-05-15 Fenwal, Inc. Biological fluid filters with molded frame and methods for making such filters
US9782707B2 (en) 2014-03-24 2017-10-10 Fenwal, Inc. Biological fluid filters having flexible walls and methods for making such filters
US10159778B2 (en) 2014-03-24 2018-12-25 Fenwal, Inc. Biological fluid filters having flexible walls and methods for making such filters
US9796166B2 (en) 2014-03-24 2017-10-24 Fenwal, Inc. Flexible biological fluid filters
US10376627B2 (en) 2014-03-24 2019-08-13 Fenwal, Inc. Flexible biological fluid filters
JP6714310B2 (en) 2015-02-20 2020-06-24 テルモ ビーシーティー、インコーポレーテッド Combined Liquid Bag System Holder
US11013850B2 (en) 2016-12-02 2021-05-25 Terumo Bct, Inc. Composite fluid separation
US11691788B1 (en) * 2022-01-20 2023-07-04 Cryoport, Inc. Foldable cassette bags for transporting biomaterials

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4388184A (en) * 1980-06-19 1983-06-14 Donald Brous Pressure and fluid flow activated, simplified proportioning system
FR2567416A2 (en) * 1981-03-09 1986-01-17 Baudry Etienne Blood stirrer
WO1992000145A1 (en) * 1990-06-26 1992-01-09 Omega Teknik Hb Method and means for blood separation
US5316540A (en) * 1993-01-13 1994-05-31 Cobe Laboratories Apparatus and method for separating microscopic units in a substantially continuous density gradient solution
WO1994025086A1 (en) * 1993-04-27 1994-11-10 Haemonetics Corporation Apheresis apparatus and method
WO1995004591A1 (en) * 1993-08-05 1995-02-16 Max-Medical Pty. Ltd. Device for mixing liquids
WO1998046362A1 (en) * 1997-04-16 1998-10-22 Omega Medicinteknik Ab Separation set for blood component preparation
EP0935966A1 (en) * 1998-02-16 1999-08-18 Möller Feinmechanik GmbH & Co. Method and apparatus for mixing fresh blood and anticoagulant

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UST955355I4 (en) 1959-06-24 1900-01-01
US3096283A (en) 1959-06-24 1963-07-02 Becton Dickinson Co Container for blood and machine for separating precipitates from liquid blood constituents
US3145713A (en) 1963-09-12 1964-08-25 Protein Foundation Inc Method and apparatus for processing blood
FR1415623A (en) 1964-08-07 1965-10-29 Citroen Sa Andre Method for improving combustion in a spark-ignition engine at idle idle speed and device for carrying out the method
US3326458A (en) 1965-05-28 1967-06-20 Harold T Meryman Container and process of storing blood
US3489145A (en) 1966-08-08 1970-01-13 Surgeon General Of The Public Method and apparatus for continuous separation of blood in vivo
US3456875A (en) 1966-08-18 1969-07-22 George N Hein Air driven centrifuge
US3519201A (en) 1968-05-07 1970-07-07 Us Health Education & Welfare Seal means for blood separator and the like
BE754683A (en) 1969-08-11 1971-01-18 Aga Ab CONTAINER INTENDED TO CONTAIN BLOOD
SE332906B (en) 1969-08-11 1971-02-22 Aga Ab
US3600900A (en) 1969-11-03 1971-08-24 North American Rockwell Temperature controlled centrifuge
SE354582B (en) 1971-03-15 1973-03-19 Aga Ab
SE354581B (en) 1971-03-15 1973-03-19 Aga Ab
US3724747A (en) 1971-03-15 1973-04-03 Aga Ab Centrifuge apparatus with means for moving material
US3737096A (en) 1971-12-23 1973-06-05 Ibm Blood processing control apparatus
SE379481B (en) 1972-11-02 1975-10-13 Separex Sa
US4934995A (en) 1977-08-12 1990-06-19 Baxter International Inc. Blood component centrifuge having collapsible inner liner
US3864089A (en) 1973-12-10 1975-02-04 Atomic Energy Commission Multiple-sample rotor assembly for blood fraction preparation
JPS50107565A (en) 1974-01-29 1975-08-25
US4018911A (en) * 1975-11-10 1977-04-19 The United States Of America As Represented By The Secretary Of The Navy Method for large volume freezing and thawing of packed erythrocytes
US4010894A (en) 1975-11-21 1977-03-08 International Business Machines Corporation Centrifuge fluid container
GB1538297A (en) 1975-11-21 1979-01-17 Access Control Syst Door lock apparatus
US4016828A (en) 1976-03-22 1977-04-12 The Perkin-Elmer Corporation Apparatus for blood film preparation
GB1584776A (en) 1976-08-06 1981-02-18 Gordon M Centrifugal homogeniser
US4111355A (en) 1977-06-15 1978-09-05 Beckman Instruments, Inc. Multi-compartment centrifuge rotor liner
US4419089A (en) 1977-07-19 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Blood cell separator
SE408859B (en) 1977-08-03 1979-07-16 Separex Sa DEVICE FOR THE OCCUPATION OF UNLIMITED CORRECT RELATIVE ROTATION BETWEEN THE ENDS OF A WIRED ELEMENT
US5006103A (en) 1977-08-12 1991-04-09 Baxter International Inc. Disposable container for a centrifuge
US5571068A (en) 1977-08-12 1996-11-05 Baxter International Inc. Centrifuge assembly
US5217426A (en) 1977-08-12 1993-06-08 Baxter International Inc. Combination disposable plastic blood receiving container and blood component centrifuge
US5217427A (en) 1977-08-12 1993-06-08 Baxter International Inc. Centrifuge assembly
US4387848A (en) 1977-10-03 1983-06-14 International Business Machines Corporation Centrifuge assembly
US4142670A (en) 1978-01-27 1979-03-06 Beckman Instruments, Inc. Chylomicron rotor
US4386730A (en) 1978-07-21 1983-06-07 International Business Machines Corporation Centrifuge assembly
SE412528B (en) 1978-07-25 1980-03-10 Separex Sa CENTRIFUGROTOR AND COLLABLE SEPARATION CONTAINER
US4244513A (en) 1978-09-15 1981-01-13 Coulter Corporation Centrifuge unit
US4303193A (en) 1979-01-22 1981-12-01 Haemonetics Corporation Apparatus for separating blood into components thereof
US4268393A (en) 1980-05-05 1981-05-19 The Institutes Of Medical Sciences Apparatus for centrifugal separation of platelet-rich plasma
US4304357A (en) 1980-06-16 1981-12-08 Haemonetics Corporation Blood processing centrifuge
US4389206A (en) 1980-10-09 1983-06-21 Baxter Travenol Laboratories, Inc. Centrifugal processing apparatus and rotatable processing bowl apparatus
US4405079A (en) 1980-11-10 1983-09-20 Haemonetics Corporation Centrifugal displacer pump
US4389207A (en) 1981-03-16 1983-06-21 Baxter Travenol Laboratories, Inc. Rotatable bowl assembly for centrifugal processing apparatus having a bonded and prewound umbilical system
US4459169A (en) 1981-03-16 1984-07-10 Baxter Travenol Laboratories, Inc. Rotatable bowl assembly for centrifugal processing apparatus having a bonded and prewound umbilical system
US4421503A (en) 1981-07-09 1983-12-20 Haemonetics Corporation Fluid processing centrifuge and apparatus thereof
US4439177A (en) 1981-10-26 1984-03-27 Beckman Instruments, Inc. Rotor bucket liner
US4447221A (en) 1982-06-15 1984-05-08 International Business Machines Corporation Continuous flow centrifuge assembly
US4482342A (en) 1982-06-17 1984-11-13 Haemonetics Corporation Blood processing system for cell washing
SE8206767D0 (en) 1982-11-26 1982-11-26 Seroteknik Hb SET AND DEVICE FOR BATTERY CENTRIFUGAL SEPARATION OF BLOOD
EP0165254A1 (en) 1983-12-13 1985-12-27 Baxter Travenol Laboratories, Inc. Flexible disposable centrifuge system
US4530691A (en) 1983-12-13 1985-07-23 Baxter Travenol Laboratories, Inc. Centrifuge with movable mandrel
ATE167087T1 (en) 1985-09-10 1998-06-15 Ver Nl Kanker Inst METHOD AND DEVICE FOR PREVENTING IMBALANCE DURING THE SEPARATION AND ISOLATION OF BLOOD OR BONE MARROW COMPONENTS
DE3786263T2 (en) 1986-05-16 1994-01-05 Omega Medicinteknik Ab Device for plasmaphoresis.
SE459791B (en) 1986-05-16 1989-08-07 Omega Medicinteknik Ab centrifuge
US4720284A (en) 1986-10-03 1988-01-19 Neotech, Inc. Method and means for separation of blood components
SE457856B (en) 1986-11-17 1989-02-06 Alfa Laval Separation Ab Centrifugal separator with an axially movable annular wear
US4940543A (en) 1987-01-30 1990-07-10 Baxter International Inc. Plasma collection set
US4767397A (en) 1987-03-09 1988-08-30 Damon Corporation Apparatus for liquid separation
SE458342B (en) 1987-07-06 1989-03-20 Alfa Laval Ab CENTRIFUGAL SEPARATOR INCLUDING A ROTOR WITH A SEPARATION CHAMBER CONSISTING OF TWO DEPARTMENTS
SE462015B (en) 1987-09-15 1990-04-30 Omega Medicinteknik Ab SETTING AND DEVICE CLEANING BLOOD CELLS
DE3815645A1 (en) 1988-05-07 1989-11-16 Biotest Pharma Gmbh A process for the production of a pure platelet concentrate from whole blood
US4846780A (en) 1988-08-10 1989-07-11 Exxon Production Research Company Centrifuge processor and liquid level control system
US4936820A (en) 1988-10-07 1990-06-26 Baxter International Inc. High volume centrifugal fluid processing system and method for cultured cell suspensions and the like
CA2013021C (en) 1989-11-29 1995-05-09 Richard Lewis Columbus Blood collection device
US5209800A (en) 1990-08-20 1993-05-11 Denco, Inc. Total containment welding of plastic tubes
JP3231086B2 (en) 1992-06-30 2001-11-19 テルモ株式会社 Liquid separation device
US5610074A (en) * 1993-02-24 1997-03-11 Beritashvili; David R. Centrifugal method and apparatus for isolating a substance from a mixture of substances in a sample liquid
SE9302369D0 (en) 1993-07-08 1993-07-08 Omega Medicinteknik Ab PASS SYSTEM PROVIDED FOR CENTRIFUGAL SEPARATION WITH USE OF THIS PASS SYSTEM
US5651766A (en) 1995-06-07 1997-07-29 Transfusion Technologies Corporation Blood collection and separation system
US5733253A (en) 1994-10-13 1998-03-31 Transfusion Technologies Corporation Fluid separation system
US5593378A (en) 1995-03-07 1997-01-14 Dyck; Howard F. Centrifugal separator for flowable mixtures and having magnets and housing scrapers
SE505621C2 (en) 1995-03-21 1997-09-22 Omega Medicinteknik Ab Methods and extractor for buffy coat harvesting from centrifugal carbonate blood vessels
US5674173A (en) 1995-04-18 1997-10-07 Cobe Laboratories, Inc. Apparatus for separating particles
US5704887A (en) 1995-06-07 1998-01-06 Baxter International Inc. Easy load umbilicus holder for a centrifuge
SE9600713L (en) 1996-02-26 1997-10-17 Omega Medicinteknik Ab Method of separating cells, especially platelets and bag set therefor
US5789259A (en) * 1996-09-27 1998-08-04 Robert A. Levine Method and apparatus for mixing samples in a capillary tube
SE9700495D0 (en) 1997-02-12 1997-02-12 Omega Medicinteknik Ab Method and round bag system and centrifuge for blood treatment
SE516321C2 (en) 1999-05-31 2001-12-17 Gambro Inc Centrifuge for the treatment of blood and blood components

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4388184A (en) * 1980-06-19 1983-06-14 Donald Brous Pressure and fluid flow activated, simplified proportioning system
FR2567416A2 (en) * 1981-03-09 1986-01-17 Baudry Etienne Blood stirrer
WO1992000145A1 (en) * 1990-06-26 1992-01-09 Omega Teknik Hb Method and means for blood separation
US5316540A (en) * 1993-01-13 1994-05-31 Cobe Laboratories Apparatus and method for separating microscopic units in a substantially continuous density gradient solution
WO1994025086A1 (en) * 1993-04-27 1994-11-10 Haemonetics Corporation Apheresis apparatus and method
WO1995004591A1 (en) * 1993-08-05 1995-02-16 Max-Medical Pty. Ltd. Device for mixing liquids
WO1998046362A1 (en) * 1997-04-16 1998-10-22 Omega Medicinteknik Ab Separation set for blood component preparation
EP0935966A1 (en) * 1998-02-16 1999-08-18 Möller Feinmechanik GmbH & Co. Method and apparatus for mixing fresh blood and anticoagulant

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7708889B2 (en) 2002-04-16 2010-05-04 Caridianbct, Inc. Blood component processing system method

Also Published As

Publication number Publication date
US20020119880A1 (en) 2002-08-29
US6740239B2 (en) 2004-05-25
SE517032C2 (en) 2002-04-02
ATE290389T1 (en) 2005-03-15
AU5120500A (en) 2001-05-08
SE9903841D0 (en) 1999-10-26
EP1223954B1 (en) 2005-03-09
JP2003535815A (en) 2003-12-02
DE60018590D1 (en) 2005-04-14
SE9903841L (en) 2000-12-01
EP1223954A1 (en) 2002-07-24
DE60018590T2 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
EP1223954B1 (en) Method and apparatus for processing blood and blood components
AU775202B2 (en) Centrifuge for processing blood and blood components in ring-type blood processing bags
EP0304431B1 (en) Apparatus for plasmapheresis
JP2743188B2 (en) Method and apparatus for washing blood cells using centrifuge
JP2644120B2 (en) How to remove impurities from blood
EP2451501B1 (en) Apparatus and method for automatically loading washing solution in a multi-unit blood processor
US8808978B2 (en) System and method for automated platelet wash
EP0679101B1 (en) Apparatus for delivering drugs into red blood corpuscles
EP1786488A1 (en) Autotransfusion method and autotransfusion device with phase separation and concentration, comprising removable bags
US6814869B2 (en) Method and an apparatus as well as a connector and a concentrate container unit for the preparation of solutions
AU2004202457B2 (en) Centrifuge for processing blood and blood components in ring type blood processing
AU2006203221B2 (en) Centrifuge for processing blood and blood components in ring type blood processing
JP2533059B2 (en) Plasma collection method
JPH05146487A (en) Dissolving device for solid dialyzing drug
JP2503020B2 (en) Plasma collection device
JPH0288073A (en) Blood plasma separator and control device for the same separator
JPH037390B2 (en)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU JP NO US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2000935797

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000935797

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2000935797

Country of ref document: EP